Document Detail

Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome.
MedLine Citation:
PMID:  21558475     Owner:  NLM     Status:  Publisher    
Objective To evaluate the predictive value of seven biomarkers, which individually have been shown to be independent predictors, for use in a combined multimarker model for long-term cardiovascular outcome after non-ST-segment elevation acute coronary syndrome (NSTEACS). Design and Setting Levels of high-sensitivity C-reactive protein (hsCRP), myeloperoxidase, pregnancy-associated plasma protein A, placental growth factor (PlGF), soluble CD40 ligand (sCD40L), interleukin 10 (IL-10) and troponin-T (TnT) were determined in patients enrolled in the CAPTURE trial. Cox proportional hazard regression analyses were applied to evaluate the relation between biomarkers and the occurrence of all-cause mortality or non-fatal myocardial infarction (MI). Patients 1090 patients with NSTEACS. Main Outcome Measure All-cause mortality and non-fatal MI during a median follow-up of 4&emsp14;years. Results The composite endpoint was reached by 15.3% of patients. Admission levels of TnT >0.01&emsp14;μg/l (adjusted HR 1.8), IL-10 <3.5&emsp14;ng/l (1.7), myeloperoxidase >350&emsp14;μg/l (1.5) and PlGF >27&emsp14;ng/l (1.9) remained significant predictors for the incidence of all-cause mortality or non-fatal MI after multivariable adjustment for other biomarkers and clinical characteristics, whereas hsCRP, pregnancy-associated plasma protein A and sCD40L were only associated with the endpoint in univariate analysis. A multimarker model consisting of TnT, IL-10, myeloperoxidase and PlGF predicted 4-year event rates that varied between 6.0% (all markers normal) and 35.8% (three or more biomarkers abnormal). Conclusion In patients with NSTEACS, biomarkers characterising distinct aspects of the underlying atherosclerotic process and myocardial damage of the initial cardiac event can assist in predicting long-term adverse cardiac outcomes. The use of combinations of selected biomarkers adds incremental predictive value to further risk stratification in an otherwise seemingly homogeneous NSTEACS population.
R M Oemrawsingh; T Lenderink; K M Akkerhuis; C Heeschen; S Baldus; S Fichtlscherer; C W Hamm; M L Simoons; E Boersma;
Related Documents :
21223485 - High-output heart failure secondary to arteriovenous fistula.
21427775 - Cerebral infarction following a seizure in a patient with subarachnoid hemorrhage compl...
20656755 - Troponin i levels in asymptomatic patients on haemodialysis using a high-sensitivity as...
21212995 - Ischaemic stroke after acute intracranial haemorrhage in patients with moyamoya disease...
19577075 - Chronic septal infarction confers right ventricular protection during mechanical left v...
17563095 - Percutaneous left ventricular assist device complicated by a patent foramen ovale: impo...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-10
Journal Detail:
Title:  Heart (British Cardiac Society)     Volume:  -     ISSN:  1468-201X     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602087     Medline TA:  Heart     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Cardiology, ErasmusMC and Cardiovascular Research Institute COEUR, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A workforce-based study of occupational exposures and asthma symptoms in cleaning workers.
Next Document:  Red cell distribution width outperforms other potential circulating biomarkers in predicting surviva...